We report a patient with novel pathogenic compound heterozygous <i>RAG2</i> variants that result in a CID phenotype with two distinctive characteristics: late-onset progressive hypogammaglobulinemia and highly elevated B cell count. This evidence concerns the gene RAG2 and combined immunodeficiency.